Insperity shares plunge as healthcare costs drive Q3 loss

Published 03/11/2025, 23:12
Insperity shares plunge as healthcare costs drive Q3 loss

Investing.com -- Insperity Inc. (NYSE:NSP) shares tumbled 27.9% in after-hours trading Monday after the human resources solutions provider reported a significant third-quarter earnings miss and slashed its full-year outlook due to unexpectedly high healthcare costs.

The company reported a third-quarter adjusted loss of -$0.20 per share, falling well short of analysts’ expectations for a $0.22 profit. Revenue came in at $1.62 billion, slightly below the consensus estimate of $1.63 billion but up 4% YoY. The company’s average paid worksite employees increased 1% to 312,842 compared to the same period last year.

Insperity attributed the disappointing results primarily to "higher-than-expected benefits costs" driven by elevated inpatient, outpatient, and pharmacy trends, along with increased frequency of large claims. Gross profit decreased 15% to $195 million from $229 million in the year-ago quarter.

"We are actively working to position Insperity for sustainable profitability at normal historical levels as we execute on our plan in response to unexpected, elevated healthcare cost trend," said Paul J. Sarvadi, Insperity chairman and chief executive officer.

The company’s outlook further alarmed investors, with fourth-quarter adjusted EPS guidance of -$0.79 to -$0.16, far below the $0.06 consensus. Full-year 2025 EPS guidance was slashed to $0.84-$1.47, compared to analyst expectations of $2.11.

In response to the challenges, Insperity announced a multi-year contract extension with UnitedHealthcare that will provide "significant cost reductions" and reduce the pooling level for large claims to $500,000 beginning January 2026.

"We believe the structure of the agreement improves our financial outlook substantially for 2026 and enhances strategic alignment for growth and profitability in subsequent years," said James D. Allison, executive vice president of finance and CFO.

The company also highlighted the official rollout of HRScale, its joint development offering with Workday, which it believes will "position Insperity uniquely within the marketplace and serve as a catalyst for future growth."

During the first nine months of 2025, Insperity returned $87 million to shareholders through share repurchases and dividends.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.